Genus plc

LSE GNS.L

Genus plc Price to Earnings Ratio (P/E) on January 14, 2025: 114.21

Genus plc Price to Earnings Ratio (P/E) is 114.21 on January 14, 2025, a 154.51% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Genus plc 52-week high Price to Earnings Ratio (P/E) is 193.51 on October 09, 2024, which is 69.44% above the current Price to Earnings Ratio (P/E).
Genus plc 52-week low Price to Earnings Ratio (P/E) is 33.76 on March 04, 2024, which is -70.44% below the current Price to Earnings Ratio (P/E).
Genus plc average Price to Earnings Ratio (P/E) for the last 52 weeks is 103.26.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

LSE: GNS.L

Genus plc

CEO	Mr. Jorgen Kokke
IPO Date	July 6, 2000
Location	United Kingdom
Headquarters	Matrix House
Employees	3,500
Sector	Health Care
Industries Biotechnology Agriculture

Description

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in reproductive, and other technical services to farmers. Genus plc has a strategic collaboration with Beijing Capital Agribusiness Co. Ltd to pursue the porcine reproductive respiratory syndrome virus resistant regulatory and development work in China. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

Key trends

Past 5 years